Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 8Terminated 5Recruiting 5Active not recruiting 3Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Leukemia, Myeloid, Acute 30Myelodysplastic Syndromes 10Recurrence 5Leukemia, Myelomonocytic, Chronic 4Leukemia 4Lymphoma, T-Cell, Peripheral 3Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Extranodal NK-T-Cell 2Hematologic Neoplasms 2Anemia, Refractory, with Excess of Blasts 2Neoplasm, Residual 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Lymphoma, T-Cell 1Lymphoma, Non-Hodgkin 1Lymphoma, B-Cell 1Lymphohistiocytosis, Hemophagocytic 1Leukemia, Myeloid 1Glioma 1Frailty 1Burkitt Lymphoma 1

Interventions

Peripheral Blood Stem Cell Transplantation 3fludarabine phosphate 2Polymerase Chain Reaction 2Cyclophosphamide 2Antilymphocyte Serum 2treosulfan 1thymoglobulin 1sargramostim 1eprenetapopt 1Whole-Body Irradiation 1Tacrolimus 1Standard of Care 1Pharmacogenomic Testing 1Mycophenolic Acid 1Methotrexate 1Mercaptopurine 1Ketamine 1Immunoenzyme Techniques 1Flow Cytometry 1Filgrastim 1Decitabine 1Cytarabine 1Cord Blood Stem Cell Transplantation 1Carboplatin 1Busulfan 1Bronchoscopy 1Bronchoalveolar Lavage 1Blood Specimen Collection 1Biopsy 1Base Sequence 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Myeloproliferative Disorders × Azacitidine × Clear all
NCT03588078 2020-01-30

Study of the Safety and Efficacy of APR-246 in Combination With Azacitidine

Groupe Francophone des Myelodysplasies

Phase 1/2 Unknown
53 enrolled
MyeloidOther hematologic neoplasm

Myeloproliferative Disorders, Leukemia, Myelomonocytic, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡